Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 4 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Results 1 - 20 of 48 : 1 2 3 Next »

Recs

0
Member Avatar MaxMilone (55.21) Submitted: 3/2/2015 7:56:54 PM : Outperform Start Price: $202.59 VRX Score: +0.18

It is in a good spot.

Recs

0
Member Avatar moneyman999 (46.13) Submitted: 2/15/2015 1:44:00 AM : Underperform Start Price: $168.17 VRX Score: -19.66

Simply overvalued,volitilty will be high but gains will be low.

Recs

0
Member Avatar freecapital (74.90) Submitted: 2/10/2015 11:37:21 PM : Outperform Start Price: $162.74 VRX Score: +22.32

Donville

Recs

0
Member Avatar 10x2 (61.71) Submitted: 1/30/2015 8:17:37 PM : Outperform Start Price: $158.00 VRX Score: +23.53

Sabrient pick.

Recs

0
Member Avatar reddingrunner (95.92) Submitted: 1/16/2015 1:33:28 PM : Outperform Start Price: $155.58 VRX Score: +24.91

sabrient bakers dozen 2015

Recs

0
Member Avatar 1russianguy (81.23) Submitted: 1/15/2015 9:17:14 AM : Outperform Start Price: $158.00 VRX Score: +23.53

Sabrient

Recs

0
Member Avatar mrudolph72 (61.24) Submitted: 1/14/2015 3:10:34 PM : Outperform Start Price: $157.00 VRX Score: +23.69

Sabrient

Recs

0
Member Avatar Defshark82 (62.38) Submitted: 12/31/2014 11:46:13 AM : Outperform Start Price: $143.88 VRX Score: +39.27

top pick JPM tracker

Recs

0
Member Avatar mlarms (< 20) Submitted: 7/31/2014 2:24:29 AM : Outperform Start Price: $118.88 VRX Score: +62.50

My big Pharma pick

Recs

0
Member Avatar TerryHoodSr (75.06) Submitted: 6/16/2014 10:58:46 AM : Outperform Start Price: $117.81 VRX Score: +63.37

VRX EPS 1YR 60% 3YR 50% 5YR 55%
CURR EPS 2.89 NEXT YR EPS 10.54
NEXT YR PE 11

Recs

0
Member Avatar chipotlepickle (98.44) Submitted: 6/15/2014 5:21:26 PM : Underperform Start Price: $118.81 VRX Score: -61.65

Running out of one time events.

Recs

0
Member Avatar ValueSwap (< 20) Submitted: 6/12/2014 3:29:27 PM : Outperform Start Price: $120.02 VRX Score: +59.63

How R&D should work and their aggressive capitalizing interest to generate a low tax rate create much fuzz about the company, which in turn give a long term holder a good entry point

Recs

0
Member Avatar IanERichards (84.94) Submitted: 6/4/2014 7:37:57 AM : Outperform Start Price: $131.15 VRX Score: +44.80

Focus on capital allocation - creative approach to making a deal

Recs

0
Member Avatar RickP (84.76) Submitted: 5/18/2014 6:17:33 PM : Outperform Start Price: $125.85 VRX Score: +48.51

Great CEO......

Fantastic future regardless of whether Allergen merger occurs or not

Recs

0
Member Avatar RLBOWERSOX (97.78) Submitted: 3/31/2014 4:40:45 PM : Outperform Start Price: $132.07 VRX Score: +40.89

One of the final four

Recs

0
Member Avatar mrwrong (< 20) Submitted: 3/29/2014 2:06:48 PM : Underperform Start Price: $129.27 VRX Score: -43.62

growth will stall as company comes a cropper, with a bridge too far. most all- do, but i like it now.

Recs

0
Member Avatar motto1628 (56.83) Submitted: 3/25/2014 4:05:57 PM : Outperform Start Price: $132.26 VRX Score: +40.31

- genius CEO in acquisition
- diversified pharmaceutical products
- stock advisor pick

Recs

0
Member Avatar mtbound (44.66) Submitted: 3/1/2014 12:25:37 PM : Outperform Start Price: $143.30 VRX Score: +27.08

I'm here mainly because of leadership. I've bought in to extraordinary leadership extracting value.

Recs

0
Member Avatar lapinkpanther (68.40) Submitted: 2/24/2014 2:58:06 PM : Outperform Start Price: $145.96 VRX Score: +25.06

Great Management!

Recs

0
Member Avatar bradrimm (61.25) Submitted: 2/9/2014 9:55:01 AM : Outperform Start Price: $138.21 VRX Score: +29.11

Strips dead wood. Value adding. Good macro scene

Results 1 - 20 of 48 : 1 2 3 Next »

Featured Broker Partners


Advertisement